Kaneka Corporation 4118
TSE · Japan · Process Industries
¥5,941.00-110.00 (-1.82%)
Market open· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Therapeutic Apheresis Market size & share revenue was valued at approximately USD 3.84 Billion in 2025 and is expected to reach USD 4.18 Billion in 2026 and is expected to reach around USD 8.94 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius K
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular divisionIRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Toro 88 Superbore Catheter, marking a transformative milestone for the company and the commercial introduction of its first proprietary neurovascular access catheter platform. The Toro 88 Catheter was purpose-built for the evol
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.